Arzeda, founded in 2009 and headquartered in the United States, is a leading name in the synthetic biology sphere. The company's slogan, The Protein Design Company™, reflects its core mission of engineering novel proteins, enzymes, and specialty chemical products. These innovations are not only performance-driven but also emphasize cost-effectiveness and sustainability.
Arzeda operates at the intersection of AI, Biotechnology, and Manufacturing, making significant strides by partnering with Fortune 500 companies. Their product portfolio serves a broad range of sectors, including polymers, pharmaceuticals, and industrial chemicals.
Notably, Arzeda secured a $7.80M grant investment in September 2025 from the National Science Foundation. This investment underscores the potential and credibility of their innovations within the scientific and industrial community.